Author: Dr Clemens

Uncategorized Published - 21 December, 2015    By - Dr Clemens
An estimation for an appropriate end time for an intraoperative intravenous lidocaine infusion in bowel surgery: a comparative meta-analysis

Published in J Clin Anesth, 2015 Authors: Khan JS et al STUDY OBJECTIVE: There exists no commonly accepted regimen for an intravenous lidocaine infusion (IVLI). This study aims to determine an appropriate end time for an IVLI during bowel surgery. DESIGN: A systematic search for randomized controlled trials assessing IVLI for bowel surgery was conducted using Ovid […]

Read More
Uncategorized Published - 21 December, 2015    By - Dr Clemens
Ultrasound-guided transversus abdominis plane block in patients undergoing open inguinal hernia repair: 0.125% bupivacaine provides similar analgesic effect compared to 0.25% bupivacaine.

Published in J Clin Anesth, 2015 Sep Authors: Erdogan Ari D et al STUDY OBJECTIVE: To evaluate the effectiveness of 0.125% bupivacaine compared to 0.25% bupivacaine for ultrasound-guided transversus abdominis plane (TAP) block in patients undergoing open inguinal hernia repair. DESIGN: Randomized, double-blind study. SETTING: Educational and research hospital. PATIENTS: Forty adult patients of American Society of […]

Read More
Uncategorized Published - 21 December, 2015    By - Dr Clemens
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial

Anesthesia & Analgesia: November 2015 Vol 121 Issue 5 p 1157-1164 Authors: Kleine-Brueggeney, Maren MD et al BACKGROUND: Evidence suggests that cannabinoids can prevent chemotherapy-induced nausea and vomiting. The use of tetrahydrocannabinol (THC) has also been suggested for the prevention of postoperative nausea and vomiting (PONV), but evidence is very limited and inconclusive. To evaluate […]

Read More
Uncategorized Published - 18 December, 2015    By - Dr Clemens
Gabapentin in Headache Disorders: What Is the Evidence?

Pain Med,2015 Sep 23. Authors: Perloff MD et al OBJECTIVE: Gabapentin (GBP), originally an antiepileptic drug, is more commonly used in the treatment of pain, including headache disorders. Off-label GBP is used in headache disorders with some success, some failure, and much debate. Due to this ambiguity, a clinical evidence literature review was performed investigating GBP’s […]

Read More
Uncategorized Published - 18 December, 2015    By - Dr Clemens
Postextubation laryngeal edema and stridor resulting in respiratory failure in critically ill adult patients: updated review

Crit Care, 2015 Sep 23;19(1):295. Authors: Pluims WA et al Endotracheal intubation is frequently complicated by laryngeal edema, which may present as postextubation stridor or respiratory difficulty or both. Ultimately, postextubation laryngeal edema may result in respiratory failure with subsequent reintubation. Risk factors for postextubation laryngeal edema include female gender, large tube size, and prolonged intubation. Although […]

Read More
Uncategorized Published - 18 December, 2015    By - Dr Clemens
New Guidelines on the Use of Prescription Medications for the Treatment of Opioid Addiction

Medications play an important role in managing patients with opioid use disorders, but there are not enough physicians with the knowledge and ability to use these often-complex treatments. New evidence-based recommendations on the use of prescription medications for the treatment of opioid addiction are published in the October/November issue of the Journal of Addiction Medicine, the […]

Read More
Uncategorized Published - 18 December, 2015    By - Dr Clemens
Gene Therapy Offers Long-Term Pain Relief for Patients With Painful Diabetic Neuropathy

Painful diabetic peripheral neuropathy (DPN) can be effectively treated with hepatocyte growth factor gene therapy, according to results of a phase 2 clinical trial presented at the 140th Annual Meeting of the American Neurological Association (ANA). “Diabetic peripheral neuropathy can cause debilitating pain with no effective treatment, and hepatocyte growth factor has potent neurotropic and […]

Read More
Uncategorized Published - 18 December, 2015    By - Dr Clemens
Very Low Frequency Deep-Brain Stimulation Improves Neuropathic Pain After Spinal-Cord Injury

Very low frequency (<2 Hz) stimulation may be more effective at controlling neuropathic pain in patients with spinal-cord injury than higher frequencies (>10 Hz), according to a small, 2-subject study presented on September 28 at the 140th Annual Meeting of the American Neurological Association (ANA). Corneliu Luca MD, PhD, University of Miami Health System, Miami, […]

Read More
Uncategorized Published - 17 December, 2015    By - Dr Clemens
Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety

Headache, 2015 Oct;55(9):1192-208. Authors: Johnson JL et al BACKGROUND: Medication overuse headache (MOH) is a condition bordering between a chronic pain condition and a substance dependence disorder. Activation of immunocompetent glial cells in the central nervous system has been linked to both pathological pain and drug addiction/reward. Preclinically, ibudilast attenuates glial activation and is able to reduce […]

Read More
Uncategorized Published - 17 December, 2015    By - Dr Clemens
Does Extended-Release Liposomal Bupivacaine Better Control Pain Than Bupivacaine After Total Knee Arthroplasty (TKA)? A Prospective, Randomized Clinical Trial.

J Arthroplasty, 2015 Sep;30 Authors: Schroer WC et al Liposomal bupivacaine periarticular injection (PAI) offers sustained bupivacaine release after TKA, but few prospective independent studies exist. In this prospective, blinded study, liposomal bupivacaine was randomized against bupivacaine and incorporated into a comprehensive multimodal pain management protocol. 111 primary TKAs were randomized to receive PAI: 58 patients received […]

Read More